The little available evidence in insulin-injected animals suggests that INSR activation may still be triggered in animal models of AD, even following HFD-induced insulin resistance, similar to the treatment of advanced T2DM [115, 123, 166]. This evidence concerns the gene INSR and Alzheimer disease.